Medtronic (MDT) Cash from Operations Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 20.35% |
| Oct 24, 2025 | 0.11% |
| Jul 25, 2025 | 0.15% |
| Apr 25, 2025 | 7.11% |
| Jan 24, 2025 | 4.90% |
| Oct 25, 2024 | -18.49% |
| Jul 26, 2024 | -8.62% |
| Apr 26, 2024 | 16.75% |
| Jan 26, 2024 | 1.64% |
| Oct 27, 2023 | -29.18% |
| Jul 28, 2023 | 46.55% |
| Apr 28, 2023 | 19.27% |
| Jan 27, 2023 | -13.20% |
| Oct 28, 2022 | -20.96% |
| Jul 29, 2022 | -10.49% |
| Apr 29, 2022 | -0.48% |
| Jan 28, 2022 | 2.73% |
| Oct 29, 2021 | 15.00% |
| Jul 30, 2021 | -8.78% |
| Apr 30, 2021 | 18.90% |
| Jan 29, 2021 | 5.58% |
| Oct 30, 2020 | 27.07% |
| Jul 31, 2020 | -27.75% |
| Apr 24, 2020 | -6.48% |
| Jan 24, 2020 | 4.90% |
| Oct 25, 2019 | 8.25% |
| Jul 26, 2019 | -0.87% |
| Apr 26, 2019 | 16.32% |
| Jan 25, 2019 | 4.57% |
| Oct 26, 2018 | -3.12% |
| Jul 27, 2018 | 27.77% |
| Apr 27, 2018 | -18.42% |
| Jan 26, 2018 | 4.25% |
| Oct 27, 2017 | -0.22% |
| Jul 28, 2017 | 33.47% |